Bubendorf/Basel, Switzerland and Kyoto, Japan, July 10, 2013 – GlyTech, Inc. (Kyoto, Japan) and Bachem AG (Bubendorf, Switzerland) informed that they have successfully co-developed a chemical synthesis of Interferon β-1a for industrial scale.
Pioneering breakthrough in the chemical synthesis of Interferon β-1a
July 10, 2013
At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.
View all jobs
Click here >>